LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 64 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $271,000 | -31.9% | 42,197 | 0.0% | 0.00% | – |
| Q4 2018 | $398,000 | -76.8% | 42,197 | -50.5% | 0.00% | -100.0% |
| Q3 2018 | $1,716,000 | +31.1% | 85,216 | +89.8% | 0.00% | 0.0% |
| Q2 2018 | $1,309,000 | +7.6% | 44,886 | +9.9% | 0.00% | 0.0% |
| Q1 2018 | $1,216,000 | -11.0% | 40,826 | -3.8% | 0.00% | 0.0% |
| Q4 2017 | $1,366,000 | -14.7% | 42,458 | -7.8% | 0.00% | 0.0% |
| Q3 2017 | $1,602,000 | +14.4% | 46,063 | -2.1% | 0.00% | 0.0% |
| Q2 2017 | $1,400,000 | +29.0% | 47,043 | +29.5% | 0.00% | 0.0% |
| Q1 2017 | $1,085,000 | +59.3% | 36,340 | -6.5% | 0.00% | 0.0% |
| Q4 2016 | $681,000 | -33.2% | 38,856 | -9.3% | 0.00% | 0.0% |
| Q3 2016 | $1,019,000 | +47.9% | 42,843 | -0.5% | 0.00% | 0.0% |
| Q2 2016 | $689,000 | -20.7% | 43,053 | +3.6% | 0.00% | 0.0% |
| Q1 2016 | $869,000 | -22.5% | 41,570 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $1,122,000 | +2.5% | 41,570 | +5.5% | 0.00% | 0.0% |
| Q3 2015 | $1,095,000 | +137.5% | 39,401 | +109.3% | 0.00% | – |
| Q2 2015 | $461,000 | – | 18,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|